[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "(804) 487-8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 561331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 342828, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigitte  Robertson M.D.", "age": 60, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abel  Svitavsky CPA", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3703, "open": 0.39, "dayLow": 0.375, "dayHigh": 0.39, "regularMarketPreviousClose": 0.3703, "regularMarketOpen": 0.39, "regularMarketDayLow": 0.375, "regularMarketDayHigh": 0.39, "payoutRatio": 0.0, "beta": 1.363, "forwardPE": -0.28496242, "volume": 404021, "regularMarketVolume": 404021, "averageVolume": 1939598, "averageVolume10days": 684320, "averageDailyVolume10Day": 684320, "bid": 0.266, "ask": 0.4947, "bidSize": 2, "askSize": 2, "marketCap": 8272894, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 1.3, "allTimeHigh": 236.0, "allTimeLow": 0.22, "fiftyDayAverage": 0.3908, "twoHundredDayAverage": 0.63095, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2168008, "profitMargins": 0.0, "floatShares": 21719729, "sharesOutstanding": 21828215, "sharesShort": 1229455, "sharesShortPriorMonth": 1839059, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0563, "heldPercentInsiders": 0.02465, "heldPercentInstitutions": 0.02616, "shortRatio": 2.22, "shortPercentOfFloat": 0.056599997, "impliedSharesOutstanding": 22596537, "bookValue": 0.26, "priceToBook": 1.4576924, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8449950, "trailingEps": -0.74, "forwardEps": -1.33, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.261, "52WeekChange": -0.61855674, "SandP52WeekChange": 0.17741585, "quoteType": "EQUITY", "currentPrice": 0.379, "targetHighPrice": 3.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.16667, "targetMedianPrice": 2.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5914980, "totalCashPerShare": 0.271, "ebitda": -8301644, "totalDebt": 0, "quickRatio": 4.884, "currentRatio": 5.019, "returnOnAssets": -0.88318, "returnOnEquity": -1.7126801, "freeCashflow": -3548171, "operatingCashflow": -6482581, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ADIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.3494499, "regularMarketPrice": 0.379, "marketState": "REGULAR", "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "corporateActions": [], "regularMarketTime": 1759418646, "exchange": "NCM", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532698200000, "regularMarketChange": 0.008700013, "regularMarketDayRange": "0.375 - 0.39", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1939598, "fiftyTwoWeekLowChange": 0.15900001, "fiftyTwoWeekLowChangePercent": 0.7227273, "fiftyTwoWeekRange": "0.22 - 1.3", "fiftyTwoWeekHighChange": -0.92099994, "fiftyTwoWeekHighChangePercent": -0.7084615, "fiftyTwoWeekChangePercent": -61.855675, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.74, "epsForward": -1.33, "epsCurrentYear": -0.64333, "priceEpsCurrentYear": -0.58912224, "fiftyDayAverageChange": -0.011799991, "fiftyDayAverageChangePercent": -0.03019445, "twoHundredDayAverageChange": -0.25194997, "twoHundredDayAverageChangePercent": -0.39931846, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Adial Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-02"}]